Allarity Therapeutics, Inc. (ALLR) Tops Q1 EPS by 763c
Tweet
Share
E-mailGet Alerts ALLR Hot Sheet
Join SI Premium – FREE
Allarity Therapeutics, Inc. (NASDAQ: ALLR) reported Q1 EPS of ($0.25), $7.63 better than the analyst estimate of ($7.88).
For earnings history and earnings-related data on Allarity Therapeutics, Inc. (ALLR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
